http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29507508

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 1856
issn 0735-1097
issueIdentifier 19
pageRange 1852-1856
publicationName Journal of the American College of Cardiology
startingPage 1852
bibliographicCitation Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, Peters G, Wickens M, Emanuelsson H, Gurbel P, Grande P, Cannon CP. Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology. 2007 Nov;50(19):1852–6. doi: 10.1016/j.jacc.2007.07.058.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4963111378238fe435c24b2873d57c6c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c5f859d4bd3791d9f7fde6bffa76925
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fd6df645a64a67b0916f9484e5d8239
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d2a45bfea1aada1a104a4a201880a2e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46028d16876314750b5b4cfabe4994e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42ec8ea81416fb316ad4563ddfdd5fb0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8df8a1e92a31bafb00c84af549b57ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdb2bd20c830accfd6b0034b50b7b000
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0762cf1551cdcd9da92d85ec34897a58
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c23a3104596a83ba97987c076b45852
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9065acf6142f6799d5e9e9aa9fe31416
date 2007-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1016/j.jacc.2007.07.058
https://pubmed.ncbi.nlm.nih.gov/17980251
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4429
https://portal.issn.org/resource/ISSN/0735-1097
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes
discusses http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0459394
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0155432
http://id.nlm.nih.gov/mesh/M0545368
http://id.nlm.nih.gov/mesh/M0545456
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D054058Q000188
http://id.nlm.nih.gov/mesh/D004562Q000187
http://id.nlm.nih.gov/mesh/D058919
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D010974Q000187
http://id.nlm.nih.gov/mesh/D009203Q000188
http://id.nlm.nih.gov/mesh/D010975Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D010975Q000009
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D058925
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D013988Q000009
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D013988Q000008
http://id.nlm.nih.gov/mesh/D000284
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871419
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID175427101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814610

Total number of triples: 68.